|
|
|
|
|
- American Cancer Society
- Smith RA, Saslow D, Sawyer KA, Burke W, Costanza ME, Evans WP 3rd, Foster RS Jr, Hendrick E, Eyre HJ, Sener S. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003 May-Jun;53(3):141-69.
- Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002 Nov-Dec;52(6):342-62.
- Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin 2003 Jan-Feb;53(1):27-43.
- American College of Medical Genetics (ACMG)
Select Documents
- General guidance page
- Standards and Guidelines for Clinical Genetics Laboratories 2006 Edition
- Technical Standards and Guidelines for CFTR Mutation Testing 2006 Edition
- Technical Standards for Fragile X 2006 Edition
- ACMG Fragile X practice guidelines
- Technical Standards for Huntington Disease 2006 Edition
- Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick JR.
Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-154.
- American College of Obstetricians and Gynecologists, and American College of Medical Genetics.
Preconception and prenatal carrier screening for cystic fibrosis. Clinical and Laboratory Guidelines. A
merican College of Obstetricians and Gynecologists, Washington, DC;2001.
- Watson MS, Cutting GR, Desnick RJ, et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genetics in Medicine 2004;6:387-391
- Monaghan KG, Feldman GL, Palomaki GE, Spector EB, Ashkenazi Jewish Reproductive Screening Working Group and the Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee. Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population. Genetics in Medicine 2008;10:57-72.
- American College of Obstetricians and Gynecologists (ACOG)
-
ACOG Committee on Genetics. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent. Obstet. Gynecol. 2004;104:425-428.
- American College of Obstetricians and Gynecologists (ACOG). Cervical cytology screening. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2003 Aug. 11 p. (ACOG practice bulletin; no. 45).
- American College of Obstetricians and Gynecologists (ACOG). Human papillomavirus. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2005 Apr. 13 p. (ACOG practice bulletin; no. 61).
- American Society of Clinical Oncology
- Guidelines for Laboratory Testing and Result Reporting of Antibody to Hepatitis C Virus
- Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC Jr, American Society of Clinical Oncology. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007 Nov 20;25(33):5287-312.
- Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF, American Society of Clinical Oncology, College of American Pathologists. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007 Jan 1;25(1):118-45.
- Centers for Disease Control and Prevention
- Association of Molecular Pathologists (AMP)
- Association for Molecular Pathology statement. Recommendations for in-house development and
operation of molecular diagnostic tests. American Journal of Clinical Pathology.
1999;111(4):449-463.
- College of American Pathologists (CAP)
- CLIA - Clinical Laboratory Improvement Amendments
- Clinical and Laboratory Standards Institute (CLSI, formerly NCCLS)
Selected Documents:
- MM01-A2 - Molecular Diagnostic Methods for Genetic Diseases
- MM09-A - Nucleic Acid Sequencing
- MM12-A - Diagnostic Nucleic Acid Microarrays
- MM13-A - Collection, Transport, Preparation, and Storage of Specimens for Molecular Methods
- MM14-A - Proficiency Testing (External Quality Assessment) for Molecular Methods
- MM16-A - Use of External RNA Controls in Gene Expression Assays
- MM17-A - Verification and Validation of Multiplex Nucleic Acid Assays
- Clinical Molecular Genetics Society
- Eurogentest
- European Molecular Genetics Quality Network (EMQN)
- FDA (Food and Drug Administration)
-
Organisation for Economic Co-operation and Development (OECD)
-
New York State Clinical Laboratory Evaluation Program (CLEP) Laboratory Standards.
- New York State Department of Health
- New York State Department of Health. Diagnostic, monitoring, and resistance tests for HIV. New York (NY): New York State Department of Health; 2005 May. 12 p.
-
Washington State Medical Test Site Rules (Chapter 246-338 WAC).
|
This page last reviewed: 08/26/2008
|
|